Insight into the frequent occurrence of dura mater graft-associated Creutzfeldt-Jakob disease in Japan

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 10, 2013, Pages 1171-1175

  Hamaguchi, Tsuyoshi ^a   Sakai, Kenji ^a   Noguchi Shinohara, Moeko ^a   Nozaki, Ichiro ^a   Takumi, Ichiro ^b   Sanjo, Nobuo ^c   Sadakane, Atsuko ^d   Nakamura, Yosikazu ^d   Kitamoto, Tetsuyuki ^e   Saito, Nobuhito ^f   Mizusawa, Hidehiro ^c   Yamada, Masahito ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b NIPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITAL   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

^e TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN GRAFT; CADAVER; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; CREUTZFELDT JAKOB DISEASE ASSOCIATED WITH DURA MATER GRAFT; DEMOGRAPHY; DISEASE SURVEILLANCE; DURA MATER; FEMALE; HEALTH PROGRAM; HEMIFACIAL SPASM; HUMAN; INCIDENCE; JAPAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PRIORITY JOURNAL; TRIGEMINUS NEURALGIA;

EID: 84884597350     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-304850     Document Type: Article

References (39)

1. Brown P, Brandel JP, Sato T, et al. Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis 2012; 18: 901-7.
2. Brown P, Brandel JP, Preece M, et al. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology 2006; 67: 389-93. (Pubitemid 44214958)
3. Nakamura Y, Aso E, Yanagawa H. Relative risk of Creutzfeldt-Jakob disease with cadaveric dura transplantation in Japan. Neurology 1999; 53: 218-20. (Pubitemid 29329677)
4. Brown P, Preece M, Brandel JP, et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000; 55: 1075-81.
5. Hoshi K, Yoshino H, Urata J, et al. Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts in Japan. Neurology 2000; 55: 718-21.
6. Noguchi-Shinohara M, Hamaguchi T, Kitamoto T, et al. Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease. Neurology 2007; 69: 360-7. (Pubitemid 47205663)
7. Nozaki I, Hamaguchi T, Sanjo N, et al. Prospective 10-year surveillance of human prion diseases in Japan. Brain 2010; 133: 3043-57.
8. Yamada M, Noguchi-Shinohara M, Hamaguchi T, et al. Dura mater graft-associated Creutzfeldt-Jakob disease in Japan: clinicopathological and molecular characterization of the two distinct subtypes. Neuropathology 2009; 29: 609-18.
9. Hamaguchi T, Noguchi-Shinohara M, Nakamura Y, et al. Ophthalmic surgery in prion diseases. Emerg Infect Dis 2007; 13: 162-4. (Pubitemid 46057859)
10. Hamaguchi T, Noguchi-Shinohara M, Nozaki I, et al. Medical procedures and risk for sporadic Creutzfeldt-Jakob disease, Japan, 1999-2008. Emerg Infect Dis 2009; 15: 265-71.
11. Nakamura Y, Uehara R, Watanabe M, et al. Update: Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts - Japan, 1978-2008. MMWR Morb Mortal Wkly Rep 2008; 57: 1152-4.
12. Heath CA, Barker RA, Esmonde TF, et al. Dura mater-associated Creutzfeldt-Jakob disease: experience from surveillance in the UK. J Neurol Neurosurg Psychiatry 2006; 77: 880-2. (Pubitemid 44023187)
13. Hannah EL, Belay ED, Gambetti P, et al. Creutzfeldt-Jakob disease after receipt of a previously unimplicated brand of dura mater graft. Neurology 2001; 56: 1080-3. (Pubitemid 32336317)
14. Pocchiari M, Masullo C, Salvatore M, et al. Creutzfeldt-Jakob disease after non-commercial dura mater graft. Lancet 1992; 340: 614-15.
15. Shimamoto T, Iso H, Iida M, et al. Epidemiology of cerebrovascular disease: stroke epidemic in Japan. J Epidemiol 1996; 6:S43-7. (Pubitemid 126839381)
16. Shimamoto T, Komachi Y, Inada H, et al. Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation 1989; 79: 503-15. (Pubitemid 19087701)
17. McLaughlin MR, Jannetta PJ, Clyde BL, et al. Microvascular decompression of cranial nerves: lessons learned after 4400 operations. J Neurosurg 1999; 90: 1-8. (Pubitemid 29024733)
18. Sekula RF Jr., Frederickson AM, Jannetta PJ, et al. Microvascular decompression for elderly patients with trigeminal neuralgia: a prospective study and systematic review with meta-analysis. J Neurosurg 2011; 114: 172-9.
19. Sekula RF, Marchan EM, Fletcher LH, et al. Microvascular decompression for trigeminal neuralgia in elderly patients. J Neurosurg 2008; 108: 689-91. (Pubitemid 351498963)
20. Fukushima T. [Posterior cranial fossa neurovascular decompression ( Jannetta method) for trigeminal neuralgia and facial spasm]. No Shinkei Geka 1982; 10: 1257-61.
21. Kuratsu J, Takeshima H, Ushio Y. Trends in the incidence of primary intracranial tumors in Kumamoto, Japan. Int J Clin Oncol 2001; 6: 183-91. (Pubitemid 32899619)
22. Nakamura H, Makino K, Yano S, et al. Epidemiological study of primary intracranial tumors: a regional survey in Kumamoto prefecture in southern Japan-20-year study. Int J Clin Oncol 2011; 16: 314-21.
23. Preston-Martin S. Descriptive epidemiology of primary tumors of the brain, cranial nerves and cranial meninges in Los Angeles County. Neuroepidemiology 1989; 8: 283-95. (Pubitemid 19265101)
24. Brooke FJ, Boyd A, Klug GM, et al. Lyodura use and the risk of iatrogenic Creutzfeldt-Jakob disease in Australia. Med J Aust 2004; 180: 177-81. (Pubitemid 38247952)
25. Collinge J, Palmer MS, Dryden AJ. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 1991; 337: 1441-2.
26. Doh-ura K, Kitamoto T, Sakaki Y, et al. CJD discrepancy. Nature 1991; 353: 801-2.
27. Dyrbye H, Broholm H, Dziegiel MH, et al. The M129V polymorphism of codon 129 in the prion gene (PRNP) in the Danish population. Eur J Epidemiol 2008; 23: 23-7.
28. Georgsson G, Tryggvason T, Jonasdottir AD, et al. Polymorphism of PRNP codons in the normal Icelandic population. Acta Neurol Scand 2006; 113: 419-25. (Pubitemid 44046328)
29. Mitrova E, Mayer V, Jovankovicova V, et al. Creutzfeldt-Jakob disease risk and PRNP codon 129 polymorphism: necessity to revalue current data. Eur J Neurol 2005; 12: 998-1001. (Pubitemid 41820056)
30. Nurmi MH, Bishop M, Strain L, et al. The normal population distribution of PRNP codon 129 polymorphism. Acta Neurol Scand 2003; 108: 374-8. (Pubitemid 37357644)
31. Zimmermann K, Turecek PL, Schwarz HP. Genotyping of the prion protein gene at codon 129. Acta Neuropathol 1999; 97: 355-8. (Pubitemid 29134515)
32. Deslys JP, Marce D, Dormont D. Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease. J Gen Virol 1994; 75:(Pt 1): 23-7. (Pubitemid 24033976)
33. Palmer MS, Dryden AJ, Hughes JT, et al. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991; 352: 340-2. (Pubitemid 21912354)
34. Kobayashi A, Asano M, Mohri S, et al. Cross-sequence transmission of sporadic Creutzfeldt-Jakob disease creates a new prion strain. J Biol Chem 2007; 282: 30022-28. (Pubitemid 350035250)
35. Heinemann U, Krasnianski A, Meissner B, et al. Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain 2007; 130: 1350-9. (Pubitemid 47355957)
36. Huillard d'Aignaux J, Costagliola D, Maccario J, et al. Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France. Neurology 1999; 53: 1197-201. (Pubitemid 29480075)
37. Prichard J, Thadani V, Kalb R, et al. Rapidly progressive dementia in a patient who received a cadaveric dura mater graft. MMWR Morb Mortal Wkly Rep 1987; 36: 49-50, 55.
38. Thadani V, Penar PL, Partington J, et al. Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. Case report. J Neurosurg 1988; 69: 766-9.
39. Shibuya K, Hashimoto H, Ikegami N, et al. Future of Japan's system of good health at low cost with equity: beyond universal coverage. Lancet 2011; 378: 1265-73.